## Abstract ## Objective This study evaluated patient and treatment (galantamine and other acetylcholinesterase inhibitors (AChEIs)) factors associated with the time until nursing home placement (NHP) in patients with Alzheimer's disease (AD) with and without cerebrovascular disease (CVD). ## Met
Donepezil treatment in Alzheimer's disease patients with and without cerebrovascular lesions: A preliminary report
β Scribed by Hae-Ri Na; SangYun Kim; Seong-Hye Choi; Dong-Won Yang; Hee-Joon Bae; Jung-Eun Kim; Mee-Young Park; Yong-Soo Shim; Byung-Kun Kim; Jae-Cheol Kwon; Bong-Goo Yoo; Byeong-Chae Kim; Jung-Seok Lee
- Book ID
- 109005572
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 285 KB
- Volume
- 11
- Category
- Article
- ISSN
- 1444-1586
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Background and Aims Donepezil hydrochloride, a central cholinergic drug, is widely used for improving cognitive decline in Alzheimer's disease (AD). We investigated whether donepezil might affect the lower urinary tract (LUT) function in AD. ## Methods Alzheimer's Disease Assessme
This study investigates the tolerability, safety and efficacy of abrupt or stepwise switching from donepezil to memantine treatment in patients with moderate-to-severe Alzheimer's disease (AD). Outpatients (Table 1), !50 years, with dementia of the Alzheimer's type (DSM-IV-TR), MMSE 18 and receiving